CME Group Inc. $CME Stock Holdings Increased by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. increased its holdings in CME Group Inc. (NASDAQ:CME) by 137.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 721,154 shares of the financial services provider’s stock after purchasing an additional 417,342 shares during the quarter. Robeco Institutional Asset Management B.V. owned 0.20% of CME Group worth $198,764,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in CME. Wayfinding Financial LLC bought a new stake in shares of CME Group in the 1st quarter worth approximately $25,000. Webster Bank N. A. raised its holdings in shares of CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 60 shares during the period. Cornerstone Planning Group LLC raised its holdings in shares of CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 55 shares during the period. Highline Wealth Partners LLC raised its holdings in shares of CME Group by 84.3% during the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 43 shares during the period. Finally, Golden State Wealth Management LLC raised its holdings in shares of CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 98 shares during the period. 87.75% of the stock is currently owned by institutional investors.

CME Group Stock Performance

Shares of CME opened at $265.84 on Thursday. The company’s 50 day moving average price is $270.51 and its 200 day moving average price is $271.09. CME Group Inc. has a 52 week low of $213.94 and a 52 week high of $290.79. The company has a market capitalization of $95.80 billion, a PE ratio of 25.73, a PEG ratio of 4.90 and a beta of 0.41. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.91 by $0.05. The company had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.56 earnings per share. Research analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were given a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s payout ratio is currently 48.40%.

Wall Street Analysts Forecast Growth

CME has been the topic of a number of recent analyst reports. Piper Sandler boosted their price target on shares of CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a report on Tuesday, July 15th. JPMorgan Chase & Co. boosted their price target on shares of CME Group from $246.00 to $252.00 and gave the company an “underweight” rating in a report on Thursday, September 25th. Morgan Stanley boosted their price target on shares of CME Group from $303.00 to $312.00 and gave the company an “overweight” rating in a report on Wednesday. Wall Street Zen downgraded shares of CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, July 13th. Finally, Oppenheimer boosted their price objective on shares of CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research report on Thursday, July 24th. Five research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $268.71.

Insider Buying and Selling at CME Group

In other CME Group news, Director William R. Shepard bought 262 shares of the firm’s stock in a transaction on Thursday, September 25th. The stock was bought at an average cost of $265.19 per share, with a total value of $69,479.78. Following the completion of the transaction, the director directly owned 258,459 shares of the company’s stock, valued at approximately $68,540,742.21. The trade was a 0.10% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, General Counsel Jonathan L. Marcus sold 392 shares of the business’s stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the sale, the general counsel directly owned 7,851 shares of the company’s stock, valued at $2,056,962. This represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 13,043 shares of company stock valued at $3,527,956. 0.30% of the stock is currently owned by insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.